Yi Huang

4.6k total citations · 1 hit paper
58 papers, 2.5k citations indexed

About

Yi Huang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Huang has authored 58 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Huang's work include Sarcoma Diagnosis and Treatment (15 papers), Cancer-related molecular mechanisms research (13 papers) and MicroRNA in disease regulation (12 papers). Yi Huang is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Cancer-related molecular mechanisms research (13 papers) and MicroRNA in disease regulation (12 papers). Yi Huang collaborates with scholars based in China and United States. Yi Huang's co-authors include Tingting Ren, Bingxin Zheng, Wei Guo, Chenglong Chen, Kuisheng Liu, Tingting Ren, Shidong Wang, Xing Bao, Kunkun Sun and Jie Xu and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Journal of Hazardous Materials.

In The Last Decade

Yi Huang

58 papers receiving 2.5k citations

Hit Papers

Immunotherapy for osteosarcoma: Fundamental mechanism, ra... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Huang China 27 1.3k 918 741 620 536 58 2.5k
Weihong Wen China 32 1.4k 1.0× 634 0.7× 663 0.9× 349 0.6× 554 1.0× 92 2.4k
Chao Chen China 29 1.4k 1.0× 996 1.1× 817 1.1× 320 0.5× 427 0.8× 130 2.7k
Jia Li China 33 1.6k 1.2× 1.0k 1.1× 577 0.8× 647 1.0× 229 0.4× 138 3.1k
Lixiang Xue China 32 2.0k 1.5× 1.0k 1.1× 557 0.8× 372 0.6× 670 1.3× 137 3.3k
Fei Xu China 26 1.1k 0.8× 660 0.7× 796 1.1× 467 0.8× 248 0.5× 133 2.4k
Hua Ye China 27 1.7k 1.2× 1.2k 1.3× 481 0.6× 452 0.7× 347 0.6× 136 2.8k
Wenjie Zhu China 28 1.1k 0.8× 952 1.0× 625 0.8× 315 0.5× 392 0.7× 101 2.3k
Chenguang Li China 29 1.8k 1.3× 1.0k 1.1× 868 1.2× 1.1k 1.7× 357 0.7× 94 3.1k
Ke Liang China 29 2.0k 1.5× 925 1.0× 1.2k 1.7× 454 0.7× 272 0.5× 79 3.3k

Countries citing papers authored by Yi Huang

Since Specialization
Citations

This map shows the geographic impact of Yi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Huang more than expected).

Fields of papers citing papers by Yi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Huang. The network helps show where Yi Huang may publish in the future.

Co-authorship network of co-authors of Yi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Huang. A scholar is included among the top collaborators of Yi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Huang. Yi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shaosen, et al.. (2025). The role of the RING finger protein 213 gene in Moyamoya disease. Fluids and Barriers of the CNS. 22(1). 39–39. 2 indexed citations
2.
Zhou, Min, Yi Huang, Ping Xu, et al.. (2024). PRMT1 Promotes the Self‐renewal of Leukemia Stem Cells by Regulating Protein Synthesis. Advanced Science. 12(5). e2308586–e2308586. 5 indexed citations
4.
Lou, Jingbing, Boyang Wang, Wei Wang, et al.. (2023). Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression. Journal for ImmunoTherapy of Cancer. 11(4). e006808–e006808. 34 indexed citations
5.
Chen, Chenglong, et al.. (2023). Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma. Frontiers in Oncology. 13. 1192472–1192472. 5 indexed citations
6.
Lou, Jingbing, Hongliang Zhang, Qingshan Huang, et al.. (2023). The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis. Cell Death Discovery. 9(1). 64–64. 5 indexed citations
7.
Chen, Chenglong, Yu Guo, Qingshan Huang, et al.. (2022). PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma. Cancer Letters. 536. 215660–215660. 38 indexed citations
8.
Huang, Qingshan, et al.. (2021). Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma. International Journal of General Medicine. Volume 14. 4819–4827. 7 indexed citations
9.
Chen, Chenglong, Hongliang Zhang, Yiyang Yu, et al.. (2021). Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3. Aging. 13(13). 17901–17913. 12 indexed citations
10.
Niu, Jianfang, Taiqiang Yan, Wei Guo, et al.. (2020). Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy. Frontiers in Oncology. 10. 1628–1628. 44 indexed citations
11.
Ren, Tingting, Yi Huang, Yiyang Yu, et al.. (2020). <p>LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis</p>. OncoTargets and Therapy. Volume 13. 12055–12066. 29 indexed citations
12.
Cao, Yaqiang, Zhaoxiong Chen, Xingwei Chen, et al.. (2019). Accurate loop calling for 3D genomic data with cLoops. Bioinformatics. 36(3). 666–675. 44 indexed citations
13.
Yang, Kang, Wei Guo, Tingting Ren, et al.. (2019). Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. Journal of Experimental & Clinical Cancer Research. 38(1). 185–185. 22 indexed citations
14.
Han, Yu, Wei Guo, Tingting Ren, et al.. (2018). Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Letters. 440-441. 116–125. 144 indexed citations
15.
Zheng, Bingxin, Tingting Ren, Yi Huang, et al.. (2018). PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse. Journal of Hematology & Oncology. 11(1). 16–16. 114 indexed citations
16.
Zhang, Xuanping, et al.. (2017). Detecting complex indels with wide length-spectrum from the third generation sequencing data. 1980–1987. 1 indexed citations
17.
Bao, Xing, Tingting Ren, Yi Huang, et al.. (2016). Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma. Journal of Experimental & Clinical Cancer Research. 35(1). 129–129. 17 indexed citations
18.
Wang, Jie, Xiaofeng Cao, Jinhua Sun, Yi Huang, & Xiaoyan Tang. (2015). Disruption of endocrine function in H295R cell in vitro and in zebrafish in vivo by naphthenic acids. Journal of Hazardous Materials. 299. 1–9. 22 indexed citations
19.
Zhang, Jie, Jinyan Huang, Fei Yuan, et al.. (2015). Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma. Scientific Reports. 5(1). 13750–13750. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026